[Antithrombotic treatment in acute coronary syndrome]

Dtsch Med Wochenschr. 2014 Jan:139 Suppl 1:S17-22. doi: 10.1055/s-0033-1359997. Epub 2014 Jan 20.

[Article in German]

Authors

H Darius¹, H-J Rupprecht², S Genth-Zotz³, T Wittlinger⁴, R Zotz⁵

Affiliations

¹ Klinik für Kardiologie, Angiologie und Intensivmedizin, Vivantes Klinikum Neukölln, Berlin.
² II. Med. Klinik, Innere Medizin/Kardiologie/Intensivmedizin, Rüsselsheim.
³ Klinik für Innere Medizin 1, Katholisches Klinikum Mainz.
⁴ Heidekreis-Klinikum Soltau.
⁵ Kardiologie, Angiologie, Abteilung Innere Medizin III, Marienhausklinik Bitburg.

PMID: 24446037
DOI: 10.1055/s-0033-1359997

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Acute Coronary Syndrome / drug therapy*
Angioplasty, Balloon, Coronary
Anticoagulants / adverse effects
Anticoagulants / therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Fibrinolytic Agents / adverse effects
Fibrinolytic Agents / therapeutic use*
Guideline Adherence
Humans
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Purinergic P2Y Receptor Antagonists / adverse effects
Purinergic P2Y Receptor Antagonists / therapeutic use
Stents

Substances

Anticoagulants
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Purinergic P2Y Receptor Antagonists